Status:
UNKNOWN
Efficacy of Hearing-aid Treatment for Patients With Tinnitus and Co-existing Hearing Loss
Lead Sponsor:
Eye & ENT Hospital of Fudan University
Conditions:
Tinnitus, Subjective
Hearing Loss, High-Frequency
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Considering the extent to which HAs play a role in sound perception and residual hearing preservation among patients with tinnitus and co-existing HL remains a lack of compelling extensive evidence, i...
Detailed Description
In clinical practice, chronic subject tinnitus poses an important challenge. This condition can negatively affect an individual's emotional and functional well-being. In most cases, tinnitus is highly...
Eligibility Criteria
Inclusion
- Adults aged older than 18 years old and less than 70 years;
- Chronic (\>6 months) subjective tinnitus, unilateral or bilateral;
- Diagnosed with a high-frequency SNHL;
- Be available for six months after starting the study to complete the follow-up questionnaires;
- Readiness to participate in the study and sign the informed consent.
- Be covered by public health insurance and eligible for reimbursement.
Exclusion
- Objective tinnitus;
- Conductive HL;
- Unstable medical history that limits participation;
- Undergoing any other concurrent treatments on tinnitus or HL;
- Having used HAs in the past 1 year;
- Unwilling or unable to use HAs daily;
- Alcohol or drug abuse;
- Unable to read or write.
Key Trial Info
Start Date :
July 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
62 Patients enrolled
Trial Details
Trial ID
NCT05343026
Start Date
July 1 2022
End Date
December 1 2023
Last Update
April 25 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.